Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Local, Multicentre, Non-Interventional Study of Early Diagnostics of Multiple Myeloma Relapses Evaluation in Real Life Practice in the Russian Federation

NCT04985643 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04985643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04985643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Local, Multicentre, Non-Interventional Study of Early Diagnostics of Multiple Myeloma Relapses Evaluation in Real Life Practice in the Russian Federation
Lead sponsor
Takeda
Phase
Observational
Overall status
Active, not recruiting
Start date
February 18, 2022
Completion date
June 20, 2027
Enrollment
357 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma